🇺🇸 FDA
Patent

US 9663504

Salts of heterocyclic modulators of HIF activity for treatment of disease

granted A61KA61K31/4245A61K31/4439

Quick answer

US patent 9663504 (Salts of heterocyclic modulators of HIF activity for treatment of disease) held by The Board of Regents of the University of Texas System expires Mon May 25 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue May 30 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 25 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K31/4245, A61K31/4439, A61K31/454, A61K31/4545